CHANGING TRENDS IN MORTALITY FROM MALIGNANT-MELANOMA

[1] BEARDMORE GL, 1972, MELANOMA SKIN CANCER, P39

[2] BODENHAM D C, 1968, Annals of the Royal College of Surgeons of England, V43, P218

[3] CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7

[4] Elwood J M, 1975, Semin Oncol, V2, P149

[5] ELWOOD JM, 1974, CAN MED ASSOC J, V110, P913

[6] LEE JAH, 1971, JNCI-J NATL CANCER I, V47, P253

[7] LEE JAH, 1970, J NATL CANCER I, V45, P91

[8] LEE JAH, 1970, J NATL CANCER I, V44, P257

[9] LEE JAH, 1973, J INVEST DERMATOL, V59, P445

[10] MANGUS K, 1973, CANCER PHILAD, V32, P1275

[1] BEARDMORE GL, 1972, MELANOMA SKIN CANCER, P39

[2] BODENHAM D C, 1968, Annals of the Royal College of Surgeons of England, V43, P218

[3] CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7

[4] Elwood J M, 1975, Semin Oncol, V2, P149

[5] ELWOOD JM, 1974, CAN MED ASSOC J, V110, P913

[6] LEE JAH, 1971, JNCI-J NATL CANCER I, V47, P253

[7] LEE JAH, 1970, J NATL CANCER I, V45, P91

[8] LEE JAH, 1970, J NATL CANCER I, V44, P257

[9] LEE JAH, 1973, J INVEST DERMATOL, V59, P445

[10] MANGUS K, 1973, CANCER PHILAD, V32, P1275